CD2AP and Alzheimer disease: Similarly, bridging integrator 1 (BIN1) and CD2-associated protein (CD2AP), both associated with vesicle trafficking and synaptic function, are believed to modulate Aβ transcytosis across the BBB, thereby influencing the AD progression [162,165].